top of page

Another addition to kidney disease prevention

Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease. 

Based on pleitropic effects of GLP-1 agonists as a drug class, the results are not surprising and serve as a welcome addition to the armamentarium of ever increasing diabetic kidney disease drugs 

1 view0 comments

Recent Posts

See All

Kidney function after donation

The prospective study showed comparable proportion of living kidney donors and nondonors to develop hypertension (17%) over a follow up of 7.3 years New albuminuria occurred in 15% of donors versus 11


bottom of page